Regulatory Process Enhancements Can Reduce Risk for Device Manufacturers Using Local Agents

Posted 01 April 2011 | By

US-based manufacturers working with local agents to register medical devices outside the US (OUS) are at risk of legal action if they do not have a method to verify that the documentation submitted by the agent accurately represents the product that the manufacturer intends to sell in the given market.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe